(Q37304596)
Statements
Inhibition of eIF2alpha dephosphorylation maximizes bortezomib efficiency and eliminates quiescent multiple myeloma cells surviving proteasome inhibitor therapy (English)
Denis M Schewe
3 February 2009
1 reference
scientific article published on 03 February 2009